Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
about
HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathwayGene expression profile of AIDS-related Kaposi's sarcomaKSHV-Mediated Angiogenesis in Tumor ProgressionAngiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated HerpesvirusAlpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cellsLong-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8.Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factorInterleukin-8 and growth-regulated oncogene alpha mediate angiogenesis in Kaposi's sarcoma.Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.TNFα modulates Fibroblast Growth Factor Receptor 2 gene expression through the pRB/E2F1 pathway: identification of a non-canonical E2F binding motif.AIDS - Associated Kaposi's Sarcoma: A Double Jeopardy.Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors.Extracellular Hsp90 serves as a co-factor for NF-κB activation and cellular pathogenesis induced by an oncogenic herpesvirus.Latent KSHV infection increases the vascular permeability of human endothelial cells.KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development.CD13/APN is activated by angiogenic signals and is essential for capillary tube formationCirculating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells.CD4+ and CD8+ T-cell skewness in classic Kaposi sarcoma.MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signalingToward a new generation of vaccines: the anti-cytokine therapeutic vaccines.mTOR inhibitors block Kaposi sarcoma growth by inhibiting essential autocrine growth factors and tumor angiogenesis.Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059.AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa?Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells.Upregulation of human β-defensin-3 and cathelicidin LL-37 in Kaposi's sarcomaKaposi's Sarcoma-Associated Herpesvirus Subversion of the Anti-Inflammatory Response in Human Skin Cells Reveals Correlates of Latency and Disease Pathogenesis.Diagnosis and Treatment of Kaposi Sarcoma.Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties.Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication.The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells.Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications.Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus.KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2.Immune effects of bevacizumab: killing two birds with one stoneKaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes.Endothelial cell malignancies: new insights from the laboratory and clinic.
P2860
Q24541552-B5348D10-C0B8-41A3-89D3-CE18FF707A3EQ24797857-17C3039F-4FEE-4CF1-B46D-6A4C9858BC31Q26742030-BC2CD2DF-D815-4532-A6F7-2DE13F986EF7Q28750291-1E719423-1B26-4DAA-88F4-AD373A0CAA72Q33647345-9B643638-9577-4805-B941-9A83FA8FE073Q33817882-CE7AFFC9-15AA-432D-A492-147E191BCD3BQ33948194-F1324DB0-E074-4308-B1BD-8B77CF650AC9Q34354735-9B027011-CCAE-4150-87B8-EF5D3C570F7AQ34587184-D611B866-5812-436C-9ADF-7F2C2FAA63B1Q34684477-1882A61C-E98C-481C-BE3C-F38DAAB8522FQ35133282-C6F73315-78E8-41BE-90DA-110BCFED3CBCQ35139228-8B29406B-8891-44D0-B68E-051D7D18EB0CQ35298119-DA5C7DEC-F8A0-4E6E-8179-A3C960BC4D96Q35553639-1CD3E255-DA67-4C87-AFEE-6C2487397448Q35642220-070C4479-AC1B-459A-AA07-106AA909096BQ35751643-D455945E-CC86-4C78-AB2A-B71473EC510DQ35994961-7580EA02-F8A6-4196-8349-344C4E661892Q36088171-42BDF3DC-3B67-4BEE-9F2A-97A89B183C8DQ36228081-D66DCDA3-E08A-4559-AB12-0AFBB759509FQ36536313-F6760A37-6A41-428F-80EC-691DF950C5DFQ36745445-E50836D9-027D-43F9-9A22-185B3B81DF78Q36818306-22495F2B-63FC-400C-B9B9-9BA6FFF2418BQ36893107-05C621EF-F606-488F-A611-7A4AFD3590A4Q37099734-E93BC4B6-3EBC-42AB-94F7-F38B3D1ECC7AQ37195726-8304938B-5AF6-485F-B9FD-3613150F354EQ37632632-E28AAEC1-80E4-4251-995A-E8D5CB3B146AQ39190555-D68C8CAE-C642-42C0-BCA4-E680D7E5F466Q39605725-262AA402-FAB4-4440-84F4-7C338C445BE1Q39683497-C5C8DF68-DEC1-41ED-B310-C11707EC29DEQ39698307-F65F43BE-9D21-4A99-808F-E62847FA0A3CQ40040603-8559746A-8217-4FEE-BE84-C9A633783A4AQ40218296-429CEC4C-AB26-4651-86D1-EB26C625001AQ40375800-A92C6408-E734-4321-BF36-27521AEDE487Q41401879-8AE248E7-EA02-4AAB-979F-685ED77F8F01Q42141115-6CF482A9-1843-417A-9AFC-B4559A767F4CQ42551562-6B181D5D-F914-4965-8C33-5C5276E9D84DQ42562294-DEC8CBA2-DD85-480F-9166-33DD23564C80Q55332047-178A1802-C509-4DC8-9541-53A3FDFD027E
P2860
Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Vascular endothelial growth fa ...... ity and KS lesion development.
@ast
Vascular endothelial growth fa ...... ity and KS lesion development.
@en
type
label
Vascular endothelial growth fa ...... ity and KS lesion development.
@ast
Vascular endothelial growth fa ...... ity and KS lesion development.
@en
prefLabel
Vascular endothelial growth fa ...... ity and KS lesion development.
@ast
Vascular endothelial growth fa ...... ity and KS lesion development.
@en
P2093
P2860
P1476
Vascular endothelial growth fa ...... ity and KS lesion development.
@en
P2093
Gendelman R
Kowalski K
Markham PD
Samaniego F
Sonnabend JA
Watanabe Y
P2860
P304
P407
P50
P577
1998-06-01T00:00:00Z